Common and separable neural alterations in substance use disorders: A coordinate‐based meta‐analyses of functional neuroimaging studies in humans

• Published in: Human brain mapping Vol. 41; no. 16; pp. 4459 - 4477
• Main Authors: Klugah‐Brown, Benjamin, Di, Xin, Zweerings, Jana, Mathiak, Klaus, Becker, Benjamin, Biswal, Bharat
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.11.2020
• Subjects: alcohol; Cannabis; Circuits; Cocaine; Cognition & reasoning; cognition, striatum, fMRI; Cognitive ability; Disorders; Drug abuse; Drug use; Executive function; Functional magnetic resonance imaging; Medical imaging; Narcotics; Neostriatum; Neuroimaging; Nicotine; Reinforcement; reward; Substance use; Substance use disorder; Thalamus; alcohol; reward; nicotine; cocaine; cannabis; substance use disorder; cognition, striatum, fMRI
• ISSN: 1065-9471; 1097-0193
• DOI: 10.1002/hbm.25085

Delineating common and separable neural alterations in substance use disorders (SUD) is imperative to understand the neurobiological basis of the addictive process and to inform substance‐specific treatment strategies. Given numerous functional MRI (fMRI) studies in different SUDs, a meta‐analysis could provide an opportunity to determine robust shared and substance‐specific alterations. The present study employed a coordinate‐based meta‐analysis covering fMRI studies in individuals with addictive cocaine, cannabis, alcohol, and nicotine use. The primary meta‐analysis demonstrated common alterations in primary dorsal striatal, and frontal circuits engaged in reward/salience processing, habit formation, and executive control across different substances and task‐paradigms. Subsequent sub‐analyses revealed substance‐specific alterations in frontal and limbic regions, with marked frontal and insula‐thalamic alterations in alcohol and nicotine use disorders respectively. Examining task‐specific alterations across substances revealed pronounced frontal alterations during cognitive processes yet stronger striatal alterations during reward‐related processes. Finally, an exploratory meta‐analysis revealed that neurofunctional alterations in striatal and frontal reward processing regions can already be determined with a high probability in studies with subjects with comparably short durations of use. Together the findings emphasize the role of dysregulations in frontostriatal circuits and dissociable contributions of these systems in the domains of reward‐related and cognitive processes which may contribute to substance‐specific behavioral alterations. The present results emphasize the role of dysregulations in striato‐frontal circuits as shared pathological substrate across substance use disorders. In addition, the meta‐analytic findings revealed for the first time evidence for robust substance‐specific alterations in limbic‐thalamo‐frontal circuits that may contribute to substance‐specific behavioral dysregulations and furthermore suggest that dysregulations in the domains of motivational and cognitive processes are mediated by separable brain systems.